Clinical Practice Guidelines for Epidermolysis Bullosa Laboratory Diagnosis
Date
2019
Type:
Article
item.page.extent
60 p.
item.page.accessRights
item.contributor.advisor
ORCID:
Journal Title
Journal ISSN
Volume Title
Publisher
item.page.isbn
item.page.issn
item.page.issne
item.page.doiurl
item.page.other
item.page.references
Abstract
The overall objective of this guideline is to provide the user with information on the laboratory diagnosis of inherited epidermolysis bullosa (EB) to improve outcomes (Table 1). An accurate diagnosis and subclassification of EB enables (i) early prognostication of disease severity, (ii) decision making for patient management, (iii) informed genetic counselling for the patient and family and DNA‐based prenatal or preimplantation genetic diagnosis, (iv) long‐term surveillance and management of possible complications, (v) inclusion in clinical trials and (vi) precision medicine.
Description
item.page.coverage.spatial
item.page.sponsorship
Citation
British Journal of Dermatology. 2020 Mar;182(3):574-592
Keywords
Molecular diagnosis, Genetic diagnosis, Genodermatosis, Skin fragility, Epidermolysis bullosa